Cham Latest News (Switzerland)

GE HealthCare is set to report its second-quarter earnings on Wednesday morning. Analysts predict a small increase in revenue but anticipate little change in profits.

Moderna claimed promising findings from a small-sample study of their experimental customized cancer vaccine and Merck's Keytruda to treat patients with head and neck cancer.

Zug, Switzerland: Moore Hong Kong, an international accounting and advisory firm, and Yieldrive AG, the Swiss fintech company, are joining forces in Asia to provide companies and financial institutions with AI-driven ESG data

Moderna (MRNA) shares rose on Wednesday after the firm said that its experimental flu shot beat widely used vaccinations from Sanofi and GSK.

Madrigal Pharmaceuticals (MDGL) said Wednesday that it expects to get FDA clearance for its nonalcoholic steatohepatitis medication in March, sending the company's shares skyrocketing.

After Eli Lilly (LLY) decided to buy the biopharma company for $2.4 billion, shares of DICE Therapeutics (DICE) rocketed and reached an all-time high on Tuesday morning.

Investors gambled on Novavax Inc. (NVAX) as a coronavirus vaccine winner in the early days of the pandemic. In just one year, the stock increased by a mind-boggling 2,700%.